Jodas is a global, specialty, innovation driven, emerging, generic pharmaceutical company, that is asserting itself among the world’s foremost pharmaceutical companies. We began our journey of growth in the year 2006 in India, and today Jodas is a modern, research driven organization that has quality and affordability at the heart of its activities.
Our Core Therapeutic Segments:
Anti Infectives (Injectables)
Anti Cancer (Injectables & Orals)
Contrast Media – Injectables
Critical Care (Injectables & Orals)
Our dedicated team of healthcare professionals strives to bring specialty, high-quality, effective and affordable generic formulations to the market, touching millions of lives with good health.
Jodas has 40+ approved products in targeted emerging markets with State-of-the-art global-class manufacturing facilities. And has successfully commercialized 7 million Injectables in the year 2014, with unparalleled customer satisfaction.
Focused to grow further in emerging markets. The future endeavor is to be a global generic player in highly regulated markets. We are committed to be “ONE STEP BETTER”, to fulfill the unmet medical needs of the healthcare community around the globe with branded generic formulations of uncompromising quality.
|
|
|
|
|
501-1,000 employees
View all Jodas Expoim Pvt Ltd employees
|
|
|
Pharmaceuticals
|
|
|
3rd Floor, NSL Centrum, Plot No S-1, Sy No: 1043 & 1048, KPHB Phase- III, Kukatpally,, Hyderabad, Telangana, India, hyderabad 500072, IN
|
|
|
2006
|
|
|
Critical Care, Oncology, Contrast Media, Cephalosporin's
|
Jiteshkumar Dandge is the CEO of Jodas Expoim Pvt Ltd.
Find accurate personal emails, work emails and phone numbers for employees
Accelerate prospecting with instant access to 350M professionals from 40M companies with the right contact details.